129 results on '"Positron emission tomography (PET)"'
Search Results
2. [18F]FDG PET for mapping the cerebral glucose metabolic characteristics of drug-sensitive and drug-resistant epilepsy in pediatric patients
3. Discovery of a highly specific radiolabeled antibody targeting B-cell maturation antigen: Applications in PET imaging of multiple myeloma
4. Chelator boosted tumor-retention and pharmacokinetic properties: development of 64Cu labeled radiopharmaceuticals targeting neurotensin receptor
5. PET imaging of synaptic vesicle glycoprotein 2 subtype A for neurological recovery in ischemic stroke
6. Development and first-in-human study of PSMA-targeted PET tracers with improved pharmacokinetic properties
7. Preclinical evaluation of 68 Ga-labeled peptide CK2 for PET imaging of NRP-1 expression in vivo
8. STING-targeted PET imaging: unveiling tumor immunogenicity post-chemotherapy in colorectal cancer
9. Theranostic role of 89Zr- and 177Lu-labeled aflibercept in breast cancer
10. Head-to-head comparison of [11C]methionine PET, [11C]choline PET, and 4-dimensional CT as second-line scans for detection of parathyroid adenomas in primary hyperparathyroidism
11. Development of novel peptide-based radiotracers for detecting PD-L1 expression and guiding cancer immunotherapy
12. In vivo cerebral metabolic and dopaminergic characteristics in multiple system atrophy with orthostatic hypotension
13. International consensus on clinical use of presynaptic dopaminergic positron emission tomography imaging in parkinsonism
14. A comparison study of dynamic [18F]Alfatide II imaging and [11C]MET in orthotopic rat models of glioblastoma
15. ImmunoPET imaging–based pharmacokinetic profiles of an antibody and its Fab targeting endothelin A receptors on glioblastoma stem cells in a preclinical orthotopic model
16. Application of Labeled Liposomes in Imaging and Biodistribution Observation
17. Characterization of a novel model for atherosclerosis imaging: the apolipoprotein E-deficient rat
18. Assessment of resting myocardial blood flow in regions of known transmural scar to confirm accuracy and precision of 3D cardiac positron emission tomography
19. Positron emission tomography molecular imaging to monitor anti-tumor systemic response for immune checkpoint inhibitor therapy
20. A novel analytical approach for outcome prediction in newly diagnosed NSCLC based on [18F]FDG PET/CT metabolic parameters, inflammatory markers, and clinical variables
21. PET molecular imaging for pathophysiological visualization in Alzheimer’s disease
22. Usefulness of 18F-FPP-RGD2 PET in pathophysiological evaluation of lung fibrosis using a bleomycin-induced rat model
23. PET imaging of hepatocellular carcinoma by targeting tumor-associated endothelium using [68Ga]Ga-PSMA-617
24. Spatial normalization and quantification approaches of PET imaging for neurological disorders
25. Classification of 18F-Flutemetamol scans in cognitively normal older adults using machine learning trained with neuropathology as ground truth
26. Spatiotemporal dynamics of brain function during the natural course in a dental pulp injury model
27. Image-level trajectory inference of tau pathology using variational autoencoder for Flortaucipir PET
28. Processing speed dysfunction is associated with functional corticostriatal circuit alterations in childhood epilepsy with centrotemporal spikes: a PET and fMRI study
29. Clinical summary of fibroblast activation protein inhibitor-based radiopharmaceuticals: cancer and beyond
30. Visualizing dynamic changes in PD-L1 expression in non-small cell lung carcinoma with radiolabeled recombinant human PD-1
31. Role of sex hormones in modulating myocardial perfusion and coronary flow reserve
32. Tumor Imaging
33. High-resolution pediatric age–specific 18F-FDG PET template: a pilot study in epileptogenic focus localization
34. Neural correlates of beneficial effects of young plasma treatment in aged mice: PET-SPM analyses and neuro-behavioural/molecular biological studies
35. PET imaging of reactive astrocytes in neurological disorders
36. Radionuclide imaging of apoptosis for clinical application
37. A novel analytic approach for outcome prediction in diffuse large B-cell lymphoma by [18F]FDG PET/CT
38. Development of a 64Cu-labeled CD4+ T cell targeting PET tracer: evaluation of CD4 specificity and its potential use in collagen-induced arthritis
39. Can positron emission tomography–computed tomography-based three target lesions' total lesion glycolysis predict therapeutic response in Hodgkin Lymphoma?
40. Preliminary mechanistic insights of a brain-penetrant microtubule imaging PET ligand in a tau-knockout mouse model
41. ImmunoPET of trophoblast cell-surface antigen 2 (Trop-2) expression in pancreatic cancer
42. International consensus on the use of tau PET imaging agent 18F-flortaucipir in Alzheimer’s disease
43. Preclinical and clinical study on [18F]DRKXH1: a novel β-amyloid PET tracer for Alzheimer’s disease
44. What value can TSPO PET bring for epilepsy treatment?
45. Contribution of TSPO imaging in the understanding of the state of gliosis in substance use disorders
46. Kinetic modeling and parameter estimation of TSPO PET imaging in the human brain
47. PET imaging of neural activity, β-amyloid, and tau in normal brain aging
48. Positron emission tomography in the COVID-19 pandemic era
49. Improved amyloid burden quantification with nonspecific estimates using deep learning
50. PET Applications in Animal Models of Neurodegenerative and Neuroinflammatory Disorders
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.